Fueling Next-Generation MS Disease Progression Research with Valhalla Foundation Support – Read the Release

Contact Us

Investigation of Serum Based Proteomic Biomarker Signatures Relative to Steroid Responsiveness and Disease Activity Status in Relapsing Multiple Sclerosis Patients

October 26, 2022inByCommentNo Comments
Click here